Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa

Tania Metaxas, Bruno Kenfack, Jessica Sormani, Eveline Tincho, Sophie Lemoupa Makajio, Ania Wisniak, Pierre Vassilakos, Patrick Petignat, Tania Metaxas, Bruno Kenfack, Jessica Sormani, Eveline Tincho, Sophie Lemoupa Makajio, Ania Wisniak, Pierre Vassilakos, Patrick Petignat

Abstract

Background: The World Health Organization recommends thermal ablation as an alternative to cryotherapy to treat women with precancerous lesions in low-resource settings. However, limited data are available on women's experience and adverse events (AEs) of the procedure in the context of Sub-Saharan Africa. The objective of this study was to evaluate the acceptability and safety of thermal ablation in women screened positive for precancerous cervical lesions.

Methods: Asymptomatic women aged 30-49 years old living in the Dschang Health District were invited to participate in a cervical cancer screening campaign termed "3 T-Approach" (for Test-Triage and Treat). Recruited women were asked to perform HPV self-sampling followed by triage with visual assessment and treatment with thermal ablation if required. After treatment and 4-6 weeks later, interviews were conducted to assess women's experience on anxiety, discomfort, and pain during thermal ablation. AEs were recorded on pre-defined electronic forms 4-6 weeks after treatment to assess the procedure's safety.

Results: Between September 2018 and December 2020, 399 HPV-positive women (18.7% of women screened) were recruited, 236 (59.1%) had a positive visual assessment, 234 were treated by thermal ablation and 198 (84.6%) received therapy in the same visit. Treatment was not considered as painful (score ≤ 4/10) by 209 (90.9%) patients while 5 (2.5%) reported high pain (score 8-10/10). During post-treatment interviews 4-6 weeks later, most reported AEs were graded mild or moderate (grade I-II). The most frequent symptoms reported as mild AEs (grade 1-2) were vaginal watery discharge (75.5%), vaginal bloody-stained discharge (21.5%) and malodourous discharge (14.5%). None of the participants experienced serious AEs (grade 3-4) or AEs requiring admission to hospital or emergency consultation. The vast majority of women (99.6%) would agree to repeat the procedure if necessary and (99.6%) would recommend it to friends or family.

Conclusion: Thermal ablation is widely accepted by women and appears as a safe procedure. It may contribute to improving the link between screening and treatment in a single visit and to optimizing cervical cancer control in low-resource settings.

Trial registration: The study was registered on clinicaltrials.gov ( NCT03757299 ) in November 2018 (28/11/2018).

Keywords: Adverse events; Cervical cancer screening; Sub-Saharan Africa; Thermal ablation.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Cumulative persistence of adverse events over time following thermal ablation

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.
    1. WHO. World Health Organization. Draft: Global strategy towards eliminating cervical cancer as a public health problem. . 2020.
    1. WHO. A cervical cancer-free future: First-ever global commitment to eliminate a cancer. . 2020.
    1. WHO. WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. 2019.
    1. Campbell C, Kafwafwa S, Brown H, Walker G, Madetsa B, Deeny M, et al. Use of thermo-coagulation as an alternative treatment modality in a ‘screen-and-treat’ programme of cervical screening in rural Malawi. Int J Cancer. 2016;139(4):908–915. doi: 10.1002/ijc.30101.
    1. Dolman L, Sauvaget C, Muwonge R, Sankaranarayanan R. Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review. BJOG Int J Obstet Gynaecol. 2014;121(8):929–942. doi: 10.1111/1471-0528.12655.
    1. Randall TC, Sauvaget C, Muwonge R, Trimble EL, Jeronimo J. Worthy of further consideration: an updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions. Prev Med. 2019;118:81–91. doi: 10.1016/j.ypmed.2018.10.006.
    1. Mungo C, Osongo CO, Ambaka J, Randa MA, Omoto J, Cohen CR, et al. Safety and acceptability of thermal ablation for treatment of human papillomavirus among women living with HIV in Western Kenya. JCO Glob Oncol. 2020;6:1024–1033. doi: 10.1200/GO.20.00035.
    1. Viviano M, Kenfack B, Catarino R, Tincho E, Temogne L, Benski A-C, et al. Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa. BMC Womens Health. 2017;17(1):2. doi: 10.1186/s12905-016-0355-x.
    1. Tran PL, Kenfack B, Tincho Foguem E, Viviano M, Temogne L, Tebeu P-M, et al. Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting. Int J Women's Health. 2017;9:879–886. doi: 10.2147/IJWH.S142911.
    1. Sandoval M, Slavkovsky R, Bansil P, Jeronimo J, Lim J, Figueroa J, et al. Acceptability and safety of thermal ablation for the treatment of precancerous cervical lesions in Honduras. Trop Med Int Health TM IH. 2019;24(12):1391–1399. doi: 10.1111/tmi.13315.
    1. Levy J, de Preux M, Kenfack B, Sormani J, Catarino R, Tincho EF, et al. Implementing the 3T-approach for cervical cancer screening in Cameroon: preliminary results on program performance. Cancer Med. 2020;9(19):7293–7300. doi: 10.1002/cam4.3355.
    1. Ricard-Gauthier D, Wisniak A, Catarino R, van Rossum AF, Meyer-Hamme U, Negulescu R, et al. Use of smartphones as adjuvant tools for cervical Cancer screening in low-resource settings. J Low Genit Tract Dis. 2015;19(4):295–300. doi: 10.1097/LGT.0000000000000136.
    1. Fouogue JT, Kenfack B, Sando Z, Watcho P, Ngadjui E, et al. Proceedings of the 9th international congress on cervical Cancer in sub-Saharan Africa, march 29-30, 2018; Dschang - Cameroon A Brief Report. J Cancer Sci Treatment. 2019;1(3):52–56.
    1. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen. 2006;13(4):208–213. doi: 10.1177/096914130601300409.
    1. Wong Baker faces [Internet]. Wong Baker Faces. [cited 2021 May 19]. Available from:
    1. Dzuba IG, Díaz EY, Allen B, Leonard YF, Lazcano Ponce EC, Shah KV, et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med. 2002;11(3):265–275. doi: 10.1089/152460902753668466.
    1. Division of AIDS National Institute of Allergy and Infectious Diseases National Institutes of Health US Department of Health and Human Services. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, corrected version 2.1 July 2017,
    1. Haefeli M, Elfering A. Pain assessment. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. 2006;15(Suppl 1):S17–S24. doi: 10.1007/s00586-005-1044-x.
    1. Duncan ID, McKinley CA, Pinion SB, Wilson SM. A double-blind, randomized, placebo-controlled trial of prilocaine and felypressin (Citanest and Octapressin) for the relief of pain associated with cervical biopsy and treatment with the Semm coagulator. J Low Genit Tract Dis. 2005;9(3):171–175. doi: 10.1097/01.LGT.0000171663.86847.45.
    1. Pinder LF, Parham GP, Basu P, Muwonge R, Lucas E, Nyambe N, et al. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020;21(1):175–184. doi: 10.1016/S1470-2045(19)30635-7.
    1. Banerjee D, Mandal R, Mandal A, Ghosh I, Mittal S, Muwonge R, et al. A prospective randomized trial to compare safety, acceptability and efficacy of thermal ablation and cryotherapy in a screen and treat setting. Asian Pac J Cancer Prev. 2020;21(5):1391–1398. doi: 10.31557/APJCP.2020.21.5.1391.
    1. Naud PSV, Muwonge R, Passos EP, Magno V, Matos J, Sankaranarayanan R. Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2016;133(3):351–354. doi: 10.1016/j.ijgo.2015.09.035.
    1. Cubaka VK, Schriver M, Cotton P, Nyirazinyoye L, Kallestrup P. Providers’ perceptions of communication with patients in primary healthcare in Rwanda. PLoS One. 2018;13(4):e0195269. doi: 10.1371/journal.pone.0195269.
    1. Petignat P, Kenfack B. Is thermal ablation a new standard for cervical pre-cancer treatment in low-income and middle-income countries? Lancet Oncol. 2020;21(1):19–20. doi: 10.1016/S1470-2045(19)30732-6.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する